Thompson Davis & Co’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
Sell
-47
Closed -$8K 1174
2015
Q4
$8K Buy
+47
New +$8K 0.01% 726